Paper
Document
Submit new version
Download
Flag content
0

Treatment duration of adjuvant immune checkpoint inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: A prospective, multicentric cohort study

0
TipTip
Save
Document
Submit new version
Download
Flag content